Insider Trading activities of Bg Medicine, Inc. insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Bg Medicine, Inc. since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Bg Medicine, Inc. since year 2005. Table 2 shows the detailed insider transactions of Bg Medicine, Inc. since 2005. The reporting company's ticker symbol is BGMD. The reporting company's CIK number is 1407038.
The total value of stock buying since 2005 is $16,323,453.
The total value of stock sales since 2005 is $1,755,067.
The total value of stock option exercises since 2005 is $409,904.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Bg Medicine, Inc. (BGMD).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2015-12 0 $0 46,438 $26,005 0 $0
2015-07 0 $0 5,584 $12,674 0 $0
2014-12 0 $0 643,786 $204,855 0 $0
2014-04 0 $0 0 $0 12,000 $10,800
2013-01 2,250,000 $4,500,000 0 $0 0 $0
2012-11 110,000 $137,650 0 $0 0 $0
2012-09 1,381 $5,109 0 $0 0 $0
2012-08 0 $0 82 $478 0 $0
2012-06 0 $0 33,986 $186,089 0 $0
2012-05 25,008 $99,130 141 $556 100,000 $90,000
2012-04 0 $0 200,000 $1,320,000 0 $0
2012-03 0 $0 0 $0 7,009 $6,308
2012-02 2,778 $0 0 $0 0 $0
2011-11 0 $0 1,078 $4,322 336,441 $302,796
2011-09 14,000 $56,568 14 $88 0 $0
2011-02 1,646,428 $11,524,996 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Bg Medicine, Inc. insiders (BGMD)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2015-12-09 Afeyan Noubar (Director) Sale 46,438 .56 26,005
2015-07-27 Agtc Partners, L.p. (10% Owner) Sale 5,282 2.27 11,989
2014-12-11 Kania Edwin M Jr (10% Owner) Sale 387,580 .30 116,274
2014-12-10 Kania Edwin M Jr (10% Owner) Sale 114,720 .32 36,710
2014-12-09 Kania Edwin M Jr (10% Owner) Sale 132,090 .36 47,552
2014-12-03 Newcogen Group, Inc. (10% Owner) Sale 4,828 .46 2,219
2014-04-14 Adourian Aram S. (SVP & Chief Scientific Officer) Option Ex 12,000 .90 10,800
2013-01-30 Applied Genomic Technology Capital Fund Lp (10% Owner) Buy 2,000,000 2.00 4,000,000
2013-01-30 Papadopoulos Stelios (Director) Buy 250,000 2.00 500,000
2012-11-19 Posner Brian S (Director) Buy 10,000 1.16 11,650
2012-11-15 Bancel Stephane (Executive Chairman) Buy 100,000 1.26 126,000
2012-09-13 Bancel Stephane (Executive Chairman) Buy 1,381 3.70 5,109
2012-08-20 Newcogen Group, Inc. (10% Owner) Sale 82 5.83 478
2012-06-08 Muntendam Pieter (EVP, Chief Medical Officer) Sale 3,965 5.29 20,974
2012-06-07 Muntendam Pieter (EVP, Chief Medical Officer) Sale 30,021 5.50 165,115
2012-05-30 Muntendam Pieter (EVP, Chief Medical Officer) Option Ex 100,000 .90 90,000
2012-05-23 Bouvier Eric (President, CEO) Buy 10,000 3.95 39,500
2012-05-22 Posner Brian S (Director) Buy 10,000 4.04 40,400
2012-05-21 Newcogen Group, Inc. (10% Owner) Sale 141 3.95 556
2012-05-17 Bancel Stephane (Executive Chairman) Buy 5,008 3.84 19,230
2012-04-17 Gilde Europe Food & Agribusiness Partners Ii C.v. (10% Owner) Sale 200,000 6.60 1,320,000
2012-03-19 Adourian Aram S. (VP, Scientific Affairs) Option Ex 7,009 .90 6,308
2012-02-22 Bancel Stephane (Executive Chairman) Buy 2,778 .00 0
2011-11-29 Papadopoulos Stelios (Director) Sale 1,078 4.01 4,322
2011-11-09 Papadopoulos Stelios (Director) Option Ex 336,441 .90 302,796
2011-09-12 Bancel Stephane (Executive Chairman) Buy 6,000 3.63 21,768
2011-09-09 Bancel Stephane (Executive Chairman) Buy 4,000 4.30 17,200
2011-09-08 Bancel Stephane (Executive Chairman) Buy 4,000 4.40 17,600
2011-09-01 Muntendam Pieter (President, CEO) Sale 14 6.29 88
2011-02-09 Gilde Europe Food & Agribusiness Partners Ii C.v. (10% Owner) Buy 142,857 7.00 999,999
2011-02-09 St Newcogen Llc (10% Owner) Buy 1,142,857 7.00 7,999,999
2011-02-09 Applied Genomic Technology Capital Fund Lp (10% Owner) Buy 285,714 7.00 1,999,998
2011-02-09 Papadopoulos Stelios (Director) Buy 75,000 7.00 525,000

Insider trading activities including stock purchases, stock sales, and option exercises of BGMD listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Bg Medicine, Inc. (symbol BGMD, CIK number 1407038) see the Securities and Exchange Commission (SEC) website.